MT Newswires
Truist Raises Price Target on National Health Investors to $92 From $85, Keeps Buy Rating
📊
AI Sentiment
Positive
7/10
- Home
- NHI
as of 03-16-2026 3:58pm EST
$86.29
+$1.12
+1.32%
National Health Investors Inc is a self-managed REIT that owns, leases, operates, and finances the development of senior housing communities and medical facilities. It operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates the majority of revenue, includes real estate leases, mortgages, and other notes receivable related to independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment consists of ventures that own and operate independent living facilities. The company's revenues are derived from rental income, interest and other income, and resident fees and services.
| Founded: | 1991 | Country: | United States |
| Employees: | N/A | City: | MURFREESBORO |
| Market Cap: | 4.1B | IPO Year: | 1994 |
| Target Price: | $87.00 | AVG Volume (30 days): | 274.0K |
| Analyst Decision: | Buy | Number of Analysts: | 5 |
| Dividend Yield: | Dividend Payout Frequency: | monthly | |
| EPS: | 3.02 | EPS Growth: | -3.51 |
| 52 Week Low/High: | $66.41 - $91.38 | Next Earning Date: | 05-29-2026 |
| Revenue: | $375,628,000 | Revenue Growth: | 12.07% |
| Revenue Growth (this year): | 11.74% | Revenue Growth (next year): | 9.02% |
| P/E Ratio: | 28.20 | Index: | N/A |
| Free Cash Flow: | -57471000.0 | FCF Growth: | N/A |
AI-Powered NHI Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 77.02%
77.02%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K BUY Feb 26, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K BUYFeb 26, 2026 · 100% conf.
AI Prediction BUY
1D
+2.19%
$89.60
Act: -3.92%
5D
+3.61%
$90.85
20D
+5.72%
$92.69
Price: $87.68 Prob +5D: 100% AUC: 1.000
0000877860-26-000054
nhi-202602260000877860FALSE00008778602026-02-262026-02-26
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): February 26, 2026
National Health Investors Inc (Exact name of Registrant as specified in its charter)
Maryland001-1082262-1470956 (State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification No.)
222 Robert Rose Drive Murfreesboro, TN 37129 (Address of principal executive offices)
(615) 890-9100 (Registrant's telephone number, including area code)
Not Applicable (Former name, former address and former fiscal year, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each ClassTrading Symbol(s)Name of each exchange on which registered Common Stock, $0.01 par valueNHINew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition
On February 26, 2026, National Health Investors, Inc. issued a press release announcing its earnings for the quarter ended December 31, 2025. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Item 9.01. Financial Statements and Exhibits
Exhibit NumberDescription 99.1Fourth Quarter Earnings Press Release, dated February 26, 2026
104Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
National Health Investors, Inc.
Date:February 26, 2026/s/ John L. Spaid Name:John L. Spaid Title:Chief Financial Officer
2025 Q3 Q3 2025 Earnings
8-K Nov 6, 2025
2025
Q3
Q3 2025 Earnings
8-KNov 6, 2025
0000877860-25-000185
nhi-202511060000877860FALSE00008778602025-11-062025-11-06
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): November 6, 2025
National Health Investors Inc (Exact name of Registrant as specified in its charter)
Maryland001-1082262-1470956 (State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification No.)
222 Robert Rose Drive Murfreesboro, TN 37129 (Address of principal executive offices)
(615) 890-9100 (Registrant's telephone number, including area code)
Not Applicable (Former name, former address and former fiscal year, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each ClassTrading Symbol(s)Name of each exchange on which registered Common Stock, $0.01 par valueNHINew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition
On November 6, 2025, National Health Investors, Inc. issued a press release announcing its earnings for the quarter ended September 30, 2025. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Item 9.01. Financial Statements and Exhibits
Exhibit NumberDescription 99.1Third Quarter Earnings Press Release, dated November 6, 2025
104Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
National Health Investors, Inc.
Date:November 6, 2025/s/ John L. Spaid Name:John L. Spaid Title:Chief Financial Officer
2025 Q2 Q2 2025 Earnings
8-K Aug 6, 2025
2025
Q2
Q2 2025 Earnings
8-KAug 6, 2025
0000877860-25-000136
nhi-202508060000877860FALSE00008778602025-08-062025-08-06
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): August 6, 2025
National Health Investors Inc (Exact name of Registrant as specified in its charter)
Maryland001-1082262-1470956 (State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification No.)
222 Robert Rose Drive Murfreesboro, TN 37129 (Address of principal executive offices)
(615) 890-9100 (Registrant's telephone number, including area code)
Not Applicable (Former name, former address and former fiscal year, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each ClassTrading Symbol(s)Name of each exchange on which registered Common Stock, $0.01 par valueNHINew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition
On August 6, 2025, National Health Investors, Inc. issued a press release announcing its earnings for the quarter ended June 30, 2025. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Item 9.01. Financial Statements and Exhibits
Exhibit NumberDescription 99.1Second Quarter Earnings Press Release, dated August 6, 2025
104Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
National Health Investors, Inc.
Date:August 6, 2025/s/ John L. Spaid Name:John L. Spaid Title:Chief Financial Officer
Latest National Health Investors Inc. News
NHI Breaking Stock News: Dive into NHI Ticker-Specific Updates for Smart Investing
Compare NHI vs Leading Stocks
See how NHI stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "NHI National Health Investors Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.